Down syndrome and epilepsy: a nutritional connection? (Q44732130)

5 December 2017

title

Down syndrome and epilepsy: a nutritional connection? (English)

1 reference

5 December 2017

1 reference

Thiel RJ

1

1 reference

5 December 2017

Fowkes SW

series ordinal

2

1 reference

5 December 2017

publication date

1 January 2004

1 reference

5 December 2017

1 reference

5 December 2017

volume

62

1 reference

5 December 2017

issue

1

1 reference

5 December 2017

page(s)

35-44

1 reference

Metabolism of Oxygen Derivatives in Down's Syndrome

5 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900294-9

7 January 2021

Seizure Disorders in Down Syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900294-9

7 January 2021

Seizures in children with Down syndrome: etiology, characteristics and outcome.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900294-9

7 January 2021

Seizure frequency and characteristics in children with Down syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900294-9

7 January 2021

Prevalence and associated features of epilepsy in adults with Down's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900294-9

7 January 2021

Epilepsy in childhood down syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900294-9

7 January 2021

Neurodevelopmental profile of Down syndrome in Chinese children

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900294-9

7 January 2021

Oxidative stress and antioxidants in epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900294-9

7 January 2021

Impression cytology in Down's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900294-9

7 January 2021

Epileptic manifestations and vitamin B1 deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900294-9

7 January 2021

Thiamine and folate treatment of chronic epileptic patients: a controlled study with the Wechsler IQ scale

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900294-9

7 January 2021

Convulsive seizures in infants with pyridoxine-deficient diet

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900294-9

7 January 2021

Vitamin B6 and brain function in animals and man.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900294-9

7 January 2021

Electroencephalographic changes and periodontal status during short-term vitamin B-6 depletion of young, nonpregnant women.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900294-9

7 January 2021

Randomized, controlled trial of high-dose intravenous pyridoxine in the treatment of recurrent seizures in children

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900294-9

7 January 2021

CSF glutamate/GABA concentrations in pyridoxine-dependent seizures: etiology of pyridoxine-dependent seizures and the mechanisms of pyridoxine action in seizure control

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900294-9

7 January 2021

Epidemiology of pyridoxine dependent and pyridoxine responsive seizures in the UK.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900294-9

7 January 2021

Pyridoxine-dependent seizures responding to extremely low-dose pyridoxine

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900294-9

7 January 2021

The metabolism of vitamin B6 in Down's syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900294-9

7 January 2021

Blood-serotonin deficiency in Down's syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900294-9

7 January 2021

Folate therapy in epilepsy. A controlled study.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900294-9

7 January 2021

Hematological studies in children with Down syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900294-9

7 January 2021

Neurologic and evoked potential abnormalities in subtle cobalamin deficiency states, including deficiency without anemia and with normal absorption of free cobalamin.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900294-9

7 January 2021

Cobalamin (Cbl) C/D deficiency: clinical, neurophysiological and neuroradiologic findings in 14 cases.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900294-9

7 January 2021

Congenital folate malabsorption

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900294-9

7 January 2021

Bone mineral density measured by dual-energy x-ray absorptiometry and novel markers of bone formation and resorption in patients on antiepileptic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900294-9

7 January 2021

Vitamin D, calcium, and bone status in children with developmental delay in relation to anticonvulsant use and ambulatory status

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900294-9

7 January 2021

People with mental retardation have an increased prevalence of osteoporosis: a population study.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900294-9

7 January 2021

A randomized, double-blind, placebo-controlled, clinical trial of D-alpha-tocopheryl acetate (vitamin E), as add-on therapy, for epilepsy in children

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900294-9

7 January 2021

Decreased Calcium Content and 45Ca2+ Uptake in Down's Syndrome Blood Platelets

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900294-9

7 January 2021

Changed serum trace element profile in Down's syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900294-9

7 January 2021

Trace element profiles in individual blood cells from patients with Down's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900294-9

7 January 2021

Iron deficiency anaemia and febrile convulsions: case-control study in children under 2 years

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900294-9

7 January 2021

Magnesium deficiency as a cause of acute intractable seizures

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900294-9

7 January 2021

Hypomagnesemia. Physical and psychiatric symptoms

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900294-9

7 January 2021

Plasma and cerebrospinal fluid concentrations of magnesium in epileptic children

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900294-9

7 January 2021

Association of low blood manganese concentrations with epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900294-9

7 January 2021

Manganese and epilepsy: brain glutamine synthetase and liver arginase activities in genetically epilepsy prone and chronically seizured rats

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900294-9

7 January 2021

Selenium deficiency triggering intractable seizures

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900294-9

7 January 2021

Zinc reduces dentate granule cell hyperexcitability in epileptic humans

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900294-9

7 January 2021

Effects of dietary zinc status on seizure susceptibility and hippocampal zinc content in the El (epilepsy) mouse.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900294-9

7 January 2021

Zinc, copper, and iron nutriture and immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900294-9

7 January 2021

Immunodeficiency and plasma zinc levels in children with Down's syndrome: A long-term follow-up of oral zinc supplementation

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900294-9

7 January 2021

Zinc sulfate supplementation improves thyroid function in hypozincemic Down children

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900294-9

7 January 2021

Alterations in the carnitine metabolism in epileptic children treated with valproic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900294-9

7 January 2021

Effects of gabapentin on brain GABA, homocarnosine, and pyrrolidinone in epilepsy patients

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900294-9

7 January 2021

Topiramate rapidly raises brain GABA in epilepsy patients

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900294-9

7 January 2021

Homocarnosine and seizure control in juvenile myoclonic epilepsy and complex partial seizures

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900294-9

7 January 2021

Vigabatrin increases human brain homocarnosine and improves seizure control

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900294-9

7 January 2021

Homocarnosine levels in cerebrospinal fluid of patients with infantile spasms under ACTH therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900294-9

7 January 2021

Hydrogen peroxide-mediated Cu,Zn-superoxide dismutase fragmentation: protection by carnosine, homocarnosine and anserine.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900294-9

7 January 2021

Enhanced oxidative damage by the familial amyotrophic lateral sclerosis-associated Cu,Zn-superoxide dismutase mutants

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900294-9

7 January 2021

Early glycoxidation damage in brains from Down's syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900294-9

7 January 2021

Carnosine reacts with a glycated protein

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900294-9

7 January 2021

Effects of oral choline on human complex partial seizures

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900294-9

7 January 2021

Preventive effect of N(G)-nitro-L-arginine against L-cysteine-induced seizures in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900294-9

7 January 2021

Melatonin attenuates L-cysteine-induced seizures and lipid peroxidation in the brain of mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900294-9

7 January 2021

Clinical analysis of West syndrome associated with phenylketonuria

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900294-9

7 January 2021

Neurological aspects of adult phenylketonuria

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900294-9

7 January 2021

Effects of vagus nerve stimulation on amino acids and other metabolites in the CSF of patients with partial seizures

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900294-9

7 January 2021

Continuing education in neurometabolic disorders--serine deficiency disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900294-9

7 January 2021

Serum amino acids, liver status, and antiepileptic drug therapy in epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900294-9

7 January 2021

Blockade of neuropsin, a serine protease, ameliorates kindling epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900294-9

7 January 2021

Changes in the antioxidant system in epileptic children receiving antiepileptic drugs: two-year prospective studies.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900294-9

7 January 2021

Antioxidative metabolism in Down syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900294-9

7 January 2021

TREATMENT OF DOWN'S SYNDROME WITH THE "U" SERIES OF DRUGS

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900294-9

7 January 2021

Can nutritional supplements help mentally retarded children? an exploratory study.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900294-9

7 January 2021

Vitamin therapy and children with Down syndrome: a review of research

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900294-9

7 January 2021

Behavioral aspects of epilepsy in children with mental retardation.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900294-9

7 January 2021

The diversity of epilepsy in adults with severe developmental disabilities: age at seizure onset and other prognostic factors.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900294-9

7 January 2021

Nonconvulsive status epilepticus--a possible cause of mental retardation in patients with Lennox-Gastaut syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900294-9

7 January 2021

Loss of cholinergic phenotype in basal forebrain coincides with cognitive decline in a mouse model of Down's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900294-9

7 January 2021

10.1016/S0306-9877(03)00294-9

Identifiers

DOI

1 reference

5 December 2017

1 reference